- TKMR has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $115.5 million.
- TKMR traded 673,202 shares today in the pre-market hours as of 8:52 AM, representing 13.7% of its average daily volume.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in TKMR with the Ticky from Trade-Ideas. See the FREE profile for TKMR NOW at Trade-Ideas More details on TKMR: Tekmira Pharmaceuticals Corporation, a biopharmaceutical company, focuses on the research and development of RNA interference therapeutics; and provides lipid nanoparticle delivery technology to pharmaceutical partners in Canada. Currently there are 5 analysts that rate Tekmira Pharmaceuticals a buy, no analysts rate it a sell, and none rate it a hold. The average volume for Tekmira Pharmaceuticals has been 584,600 shares per day over the past 30 days. Tekmira has a market cap of $295.4 million and is part of the health care sector and drugs industry. Shares are up 79% year-to-date as of the close of trading on Thursday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.